These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 8842441)

  • 1. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
    Bileviciute-Ljungar I; Saxne T; Spetea M
    Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis.
    Walker JS; Howlett CR; Nayanar V
    Life Sci; 1995; 57(4):371-8. PubMed ID: 7603309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I; Spetea M
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C; Milanés MV; Vargas ML
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
    Micol JA; Laorden ML
    Neuropeptides; 1994 Jun; 26(6):365-70. PubMed ID: 7936123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
    Zhai QZ; Ingenito AJ
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems.
    Millan MJ; Członkowski A; Pilcher CW; Almeida OF; Millan MH; Colpaert FC; Herz A
    J Neurosci; 1987 Jan; 7(1):77-87. PubMed ID: 3027278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
    Ukai M; Suzuki M; Mamiya T
    J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
    Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
    Bileviciute-Ljungar I; Spetea M
    Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.